课题基金 / 基金详情

Retrotransposon instability in glioblastoma multiforme

Retrotransposon instability in glioblastoma multiforme
多形性胶质母细胞瘤中的逆转录转座子不稳定性
批准号:
8831175
负责人:
Jef D BOEKE
金额:
$9.63万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-16 至 2015-07-31

项目摘要

项目成果

Jef D BOEKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Aggressive brain cancers are among the most devastating of malignancies diagnosed today. Basic science researchers have shown that during the complex process of brain cancer development, there are many steps. These include the potential activation of mobile DNA sequences in our cells, though no one has had a means of studying these DNAs previously. Appropriate DNA function is at the heart of how a cell works and alterations in DNA (mutations) accompany cancer development. We propose that mobile DNA sequences known as transposons are activated in brain cancer and then in turn mutate other DNA sequences. In this way, mobile DNAs may contribute to the beginning of brain cancer development or the continued growth of disease after effective early therapy. We have developed a new technology (transposon insertion site profiling by deep sequencing or TIP-seq) that allows us to locate the most active mobile DNAs in human cells. We propose to apply TIP-seq to profile mobile DNAs genome-wide in 100 different pathologic samples from glioblastoma multiforme tumors. This should demonstrate whether mobile DNAs are unstable in human brain cancers and if they cause mutations that promote cancer biology. The project would be among the very first to address roles of mobile DNAs in human cancers, and will potentially open our eyes to mechanisms at work in many cancer types.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Assemblatron
MutSensor System: A Set of Highly Sensitive Mutation Reporters to Dissect Genome Stability in Health and Disease
eDyNAmiC - NYU
eDyNAmiC - NYU
国内基金
海外基金
雷特综合症致病蛋白MeCP2在DNA损伤修复中的功能及分子机制研究
  • 批准号:
    32070780
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    刘红美
  • 依托单位:
组蛋白去乙酰化酶SirT7翻译后修饰及其在调控肿瘤耐药中的作用研究
  • 批准号:
    32070770
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    孙莲慧
  • 依托单位:
新的FANCM关联蛋白复合物FMAP150-FMAP160调控FANCM修复停滞复制叉的作用及机制
  • 批准号:
    32070716
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    ZHIJIANG YAN
  • 依托单位:
激活SENP1-Sirt3轴改善线粒体健康对延缓衰老的作用与机制研究
  • 批准号:
    92049113
  • 项目类别:
    重大研究计划
  • 资助金额:
    60.0万元
  • 批准年份:
    2020
  • 负责人:
    王田实
  • 依托单位: